Proximal femur fractures in patients taking anticoagulants

EFORT Open Reviews
Ioannis V Papachristos, Peter V Giannoudis

Abstract

Thirty per cent of patients presenting with proximal femoral fractures are receiving anticoagulant treatment for various other medical reasons. This pharmacological effect may necessitate reversal prior to surgical intervention to avoid interference with anaesthesia or excessive peri/post-operative bleeding. Consequently, delay to surgery usually occurs.Platelet inhibitors (aspirin, clopidogrel) either alone or combined do not need to be discontinued to allow acute hip surgery. Platelet transfusions can be useful but are rarely needed.Vitamin K antagonists (VKA, e.g. warfarin) should be reversed in a timely fashion and according to established readily accessible departmental protocols. Intravenous vitamin K on admission facilitates reliable reversal, and platelet complex concentrate (PCC) should be reserved for extreme scenarios.Direct oral anticoagulants (DOAC) must be discontinued prior to hip fracture surgery but the length of time depends on renal function ranging traditionally from two to four days.Recent evidence suggests that early surgery (within 48 hours) can be safe. No bridging therapy is generally recommended.There is an urgent need for development of new commonly available antidotes for every DOAC as well as high-l...Continue Reading

References

Feb 18, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Thomas Hanslik, Jacques Prinseau
Oct 29, 2004·Journal of Clinical Pathology·J P Hanley
Jun 16, 2011·British Journal of Haematology·David KeelingUNKNOWN British Committee for Standards in Haematology
Jul 7, 2011·The Annals of Pharmacotherapy·Asad E PatanwalaBrian L Erstad
Jun 29, 2013·Internal and Emergency Medicine·Aaron Liew, James Douketis
Sep 10, 2013·Journal of Orthopaedic Surgery·Andreas LeonidouJonathan Luscombe
Nov 28, 2013·Journal of Orthopaedics and Traumatology : Official Journal of the Italian Society of Orthopaedics and Traumatology·I AhmedA Mohsen
Nov 28, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Xiaoli WangCharles Frost
Dec 18, 2013·British Journal of Anaesthesia·H T BenzonR O Bonow
Jan 5, 2014·Journal of the American Geriatrics Society·Lauren J GleasonSusan M Friedman
Aug 2, 2014·Therapeutic Advances in Drug Safety·Juan Antonio VílchezGregory Y H Lip
Sep 13, 2014·Journal of the American College of Cardiology·Adam CukerDavid A Garcia
Nov 2, 2014·Geriatric Orthopaedic Surgery & Rehabilitation·W G P EardleyA Tate
Feb 24, 2015·Seminars in Thrombosis and Hemostasis·Antonella TufanoGiovanni Di Minno
Feb 26, 2015·Journal of Orthopaedic Trauma·Devon J RyanJoseph D Zuckerman
May 15, 2015·Circulation·Sam SchulmanUNKNOWN Periop Dabigatran Study Group
Jun 23, 2015·The New England Journal of Medicine·Charles V PollackJeffrey I Weitz
Aug 14, 2015·Journal of Thrombosis and Haemostasis : JTH·C Chai-AdisaksophaM Crowther
Oct 18, 2015·British Journal of Anaesthesia·R S Vela Vásquez, R Peláez Romero
Feb 2, 2016·Annals of the Royal College of Surgeons of England·B PurushothamanA Nanu
Mar 24, 2016·BMC Musculoskeletal Disorders·Christopher G K M SooMichael A Shatwell
Aug 31, 2016·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN ANNEXA-4 Investigators
Sep 3, 2016·Clinical Orthopaedics and Related Research·John E LawrenceAndrew D Carrothers
Oct 8, 2016·British Journal of Haematology·David KeelingUNKNOWN British Committee of Standards for Haematology
Apr 22, 2017·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Jordan Leitch, Janet van Vlymen
Apr 27, 2017·Journal of Orthopaedic Trauma·Matthew R CohnJoseph M Lane
Jul 12, 2017·The New England Journal of Medicine·Charles V PollackJeffrey I Weitz
Aug 20, 2017·European Heart Journal·Anne GodierIsabelle Gouin-Thibault
Oct 27, 2017·EFORT Open Reviews·Rafik YassaPaul Dunkow
Sep 1, 2018·Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy·Vivek GulatiRobert Middleton

❮ Previous
Next ❯

Citations

Apr 22, 2021·Curēus·Vasiliki ChatziravdeliAnastasios Beletsiotis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.